Erol, C. Et Al. 2023. Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience. Journal of Oncological Science , vol.9, no.2 , 72-78.

Erol, C., Bardakçi, M., Hizal, M., Kahraman, S., Yekedüz, E., Güven, D. C., ... Aykan, M. B.(2023). Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience. Journal of Oncological Science , vol.9, no.2, 72-78.

Erol, Cihan Et Al. "Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience," Journal of Oncological Science , vol.9, no.2, 72-78, 2023

Erol, Cihan Et Al. "Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience." Journal of Oncological Science , vol.9, no.2, pp.72-78, 2023

Erol, C. Et Al. (2023) . "Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience." Journal of Oncological Science , vol.9, no.2, pp.72-78.

@article{article, author={Cihan Erol Et Al. }, title={Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience}, journal={Journal of Oncological Science}, year=2023, pages={72-78} }